|
1
|
Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY,
Chan CH, Cheung MM and Lau WH: Nonnasal lymphoma expressing the
natural killer cell marker CD56: A clinicopathologic study of 49
cases of an uncommon aggressive neoplasm. Blood. 89:4501–4513.
1997.PubMed/NCBI
|
|
2
|
Au WY, Weisenburger DD, Intragumtornchai
T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO and Liang R:
International Peripheral T-Cell Lymphoma Project: Clinical
differences between nasal and extranasal natural killer/T-cell
lymphoma: A study of 136 cases from the International Peripheral
T-Cell Lymphoma Project. Blood. 113:3931–3937. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee S, Shin B, Yoon H, Lee JY and Chon GR:
A case of primary pulmonary NK/T cell lymphoma presenting as
pneumonia. Respir Med Case Rep. 17:1–4. 2015.PubMed/NCBI
|
|
4
|
Lee BH, Kim SY, Kim MY, Hwang YJ, Han YH,
Seo JW, Kim YH, Cha SJ and Hur G: CT of nasal-type T/NK cell
lymphoma in the lung. J Thorac Imaging. 21:37–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gong L, Wei LX, Huang GS, Zhang WD, Wang
L, Zhu SJ, Han XJ, Yao L, Lan M, Li YH, et al: Identification of
genuine primary pulmonary NK cell lymphoma via clinicopathologic
observation and clonality assay. Diagn Pathol. 8:1402013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laohaburanakit P and Hardin KA: NK/T cell
lymphoma of the lung: A case report and review of literature.
Thorax. 61:267–270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chien CC, Lee HS, Lin MH and Hsieh PP:
Primary extranodal natural killer/T-cell lymphoma of bronchus and
lung: A case report and review of literature. Thorac Cancer.
7:140–144. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu CH, Wang HH, Perng CL, Peng CK, Chian
CF and Shen CH: Primary extranodal NK/T-cell lymphoma of the lung:
Mimicking bronchogenic carcinoma. Thorac Cancer. 5:93–96. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Feng W, Chen C, Zhang X, Zhu Y,
Lei W and Huang JA: Primary pulmonary T-cell lymphoma mimicking
pneumonia: A case report and literature review. Exp Ther Med.
12:365–368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fei W, Xiaohong W, Hong Z and Bei H:
Pulmonary Extranodal Natural Killer/T-Cell Lymphoma (Nasal Type): A
Case Report and Radiological Image Review. Medicine (Baltimore).
94:e15272015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gui W, Yang B, Shen Q, Bai M, Wang J, Guan
T, Zhao J, Wang J and Su L: Successful treatment with
L-asparaginase-based regimen for primary pulmonary NK/T cell
lymphoma: A case report and review of the literature. Clin Respir
J. 9:493–496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao MS, Cai HR, Yin HL, Zhang DP, Xiao YL,
Cao M, Dai LJ and Hou J: Primary natural killer/T cell lymphoma of
the lung: Two cases report and clinical analysis. Zhonghua Jie He
He Hu Xi Za Zhi. 31:120–124. 2008.(in Chinese). PubMed/NCBI
|
|
13
|
Ding W, Wang J, Zhao S, Yang Q, Sun H, Yan
J, Gao L, Yao W, Zhang W and Liu W: Clinicopathological study of
pulmonary extranodal nature killer/T-cell lymphoma, nasal type and
literature review. Pathol Res Pract. 211:544–549. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oshima K, Tanino Y, Sato S, Inokoshi Y,
Saito J, Ishida T, Fukuda T, Watanabe K and Munakata M: Primary
pulmonary extranodal natural killer/T-cell lymphoma: Nasal type
with multiple nodules. Eur Respir J. 40:795–798. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Borie R, Wislez M, Thabut G, Antoine M,
Rabbat A, Couderc LJ, Monnet I, Nunes H, Blanc FX, Mal H, et al:
Clinical characteristics and prognostic factors of pulmonary MALT
lymphoma. Eur Respir J. 34:1408–1416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferraro P, Trastek VF, Adlakha H,
Deschamps C, Allen MS and Pairolero PC: Primary non-Hodgkin's
lymphoma of the lung. Ann Thorac Surg. 69:993–997. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cadranel J, Wislez M and Antoine M:
Primary pulmonary lymphoma. Eur Respir J. 20:750–762. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T,
Tse E, Leung AY and Chim CS: SMILE for natural killer/T-cell
lymphoma: Analysis of safety and efficacy from the Asia Lymphoma
Study Group. Blood. 120:2973–2980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Jia S, Ma Y, Li L, Li X, Wang X,
Fu X, Ma W, Qin Y, Li W, et al: Efficacy and safety of cisplatin,
dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly
diagnosed, advanced-stage extranodal natural killer/T-cell
lymphoma: Interim analysis of a phase 4 study NCT01501149.
Oncotarget. 7:55721–55731. 2016.PubMed/NCBI
|
|
20
|
Jaccard A, Gachard N, Marin B, Rogez S,
Audrain M, Suarez F, Tilly H, Morschhauser F, Thieblemont C,
Ysebaert L, et al: GELA and GOELAMS Intergroup: Efficacy of
L-asparaginase with methotrexate and dexamethasone (AspaMetDex
regimen) in patients with refractory or relapsing extranodal
NK/T-cell lymphoma, a phase 2 study. Blood. 117:1834–1839. 2011.
View Article : Google Scholar : PubMed/NCBI
|
